Acute migraine treatment : recommendations to optimize management
Abstract
The management of migraine, particularly the treatment of acute attacks, is frequently suboptimal, both among patients and physicians with limited expertise in this field. This situation is largely explained by the trivialization of the disease, leading to delayed healthcare seeking and inappropriate use of analgesics. Yet, migraine is a highly disabling disorder and a major public health concern. Given this substantial burden, the most immediate therapeutic strategy remains the treatment of acute attacks, with early and adequate administration increasing the likelihood of success while preventing inappropriate medication use. The aim of this article is to revisit the fundamental principles of acute migraine management in order to optimize its use, drawing on the most relevant guidelines, our clinical experience, and the Belgian pharmaco-economic context.
Le traitement de la crise de migraine fait souvent l’objet d’une utilisation suboptimale, tant par les patients que les médecins non spécialisés. Cette situation s’explique, notamment, par une banalisation de la maladie, conduisant à un recours tardif aux soins et à une utilisation inappropriée des antalgiques. Or, la migraine est une pathologie extrêmement invalidante et un problème de santé publique majeur. Face à ce fardeau considérable, la réponse thérapeutique la plus immédiate demeure le traitement des crises, dont une utilisation précoce et adéquate permet d’accroître les chances de succès, tout en évitant une…
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.